Citi said uncertainty surrounds Boston Scientific’s immediate future as headwinds are complicated by its recovery from a major cyberattack.

Medtronic’s former chief regulatory counsel, Sandra Cohen Kalter, joined Autonomix's for board of directors as it advances its catheter for mapping and treating the nervous system.

Needham analysts agreed with Medtronic’s pitch that Sentire can complement Hugo, especially in a robotic surgery market with room to grow.